NYSE·Services-Medical Laboratories

LABCORP HOLDINGS INC.

LABCORP HOLDINGS INC. (ticker: LH) is an NYSE-listed services-medical laboratories company. DredgeCap's structured extraction of LH's SEC filings surfaces 4 active risk signals, including 2 auditor-change signals, and 2 delisting/deregistration signals. LH reported $3.54B in revenue and $277.80M for the period ending 2026-03-31, with operating cash flow of $191.50M. Cash and equivalents stood at $981.10M (up 165.6% year-over-year). Total assets of $19.09B exceed total liabilities of $10.34B. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.

LH Cash Runway

Months-of-runway analysis for LH, derived directly from SEC XBRL: latest cash and operating cash flow, monthly burn rate, runway under current conditions. Historical trend + verbatim citation panel ships in Phase 2.

Coming in Phase 2

The dedicated per-ticker cash-runway page will surface a 6-8 quarter trend with the underlying us-gaap:CashAndCashEquivalentsAtCarryingValue + us-gaap:NetCashProvidedByUsedInOperatingActivities citations alongside each data point. In the meantime, see the ranked cross-company view:

All companies ranked by months-of-runway →

Related on LH

Share-count dilution →

Dilution is the natural counterpart to runway burn.

Going-concern history →

Auditor + management language across filings.